Lornoxicam protects mouse cornea from UVB-induced damage via inhibition of NF-κB activation

British Journal of Ophthalmology

Volumn 92, Issue 4, 2008, Pages 562-568

  Yin, Jie ^a   Huang, Zhenping ^a   Wu, Bo ^a   Shi, Yao ^a   Cao, Chunlin ^a   Lu, Yuwen ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LORNOXICAM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XAFON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; CORNEA; CORNEA CELL; CORNEA DISEASE; CORNEA OPACITY; CYTOKINE PRODUCTION; DNA BINDING; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; MICROSCOPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRASTRUCTURE; ULTRAVIOLET B RADIATION;

ANIMALS; CORNEA; CORNEAL OPACITY; FEMALE; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON; NF-KAPPA B; PIROXICAM; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RANDOM ALLOCATION; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 41849113101     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.129064     Document Type: Article

References (38)

1. Gray RH, Johnson GJ, Freedman A. Climatic droplet keratopathy. Surv Ophthalmol 1992;36:241-53.
2. Pitts DG, Cullen AP, Hacker PD. Ocular effects of ultraviolet radiation from 295 to 365 nm. Invest Ophthalmol Vis Sci 1977;16:932-9.
3. Nagy ZZ, Hiscott P, Seitz B, et al. Ultraviolet-B enhances corneal stromal response to 193-nm excimer laser treatment. Ophthalmology 1997;104:375-80.
4. Kim TI, Lee SY, Pak JH, et al. Mitomycin C, ceramide, and 5-fluorouracil inhibit corneal haze and apoptosis after PRK. Cornea 2006;25:55-60.
5. Laycock KA, Lee SF, Brady RH, et al. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest Ophthalmol Vis Sci 1991;32:2741-6.
6. Hill JC, Sarvan J, Maske R, et al. Evidence that UV-B irradiation decreases corneal Langerhans cells and improves corneal graft survival in the rabbit. Transplantation 1994;57:1281-4.
7. Pikarsky E, Ben-Neriah Y. NF-kappaB inhibition: a double-edged sword in cancer? Eur J Cancer 2006;42:779-84.
8. Kennedy M, Kim KH, Harten B, et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci 1997;38:2483-91.
9. Alexander G, Carlsen H, Blomhoff R. Corneal NF-kappaB activity is necessary for the retention of transparency in the cornea of UV-B-exposed transgenic reporter mice. Exp Eye Res 2006;82:700-9.
10. Lee DH, Kim JK, Joo CK. Translocation of nuclear factor-kappaB on corneal epithelial cells induced by ultraviolet B irradiation. Ophthalmic Res 2005;37:83-8.
11. Zhang MC, Wang Y, Yang Y. The expression of nuclear factor kappa B in inflammation-induced rat corneal neovascularization. Ocul Immunol lnflamm 2006;14:359-65.
12. Kase S, Aoki K, Harada T, et al. Activation of nuclear factor-kappa B in the conjunctiva with the epithelial scraping of the mouse cornea and human epidemic keratoconjunctivitis. Br J Ophthalmol 2004;88:947-9.
13. Beak SM, Lee YS, Kim JA. NADPH oxidase and cyclooxygenase mediate the ultraviolet B-induced generation of reactive oxygen species and activation of nuclear factor-kappaB in HaCaT human keratinocytes. Biochimie 2004;86:425-9.
14. Kim JK, Kim Y, Na KM, et al.[6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic Res 2007;41:603-14.
15. Pupe A, Degreef H, Garmyn M. Induction of tumor necrosis factor-alpha by UVB: a role for reactive oxygen intermediates and eicosanoids. Photochem Photobiol 2003;78:68-74.
16. Athar M, An KP, Tang X, et al. Photoprotective effects of sulindac against ultraviolet B-induced phototoxicity in the skin of SKH-1 hairless mice. Toxicol Appl Pharmacol 2004;195:370-8.
17. Wilgus TA, Koki AT, Zweifel BS, et al. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinog 2003;38:49-58.
18. Berg J, Fellier H, Christoph T, et al. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res 1999;48:369-79.
19. Radhofer-Welte S, Rabasseda X. Lornoxicam, a new potent NSAID with an improved tolerability profile. Drugs Today (Barc) 2000;36:55-76.
20. Podskochy A, Fagerholm P. Repeated UVR exposures cause keratocyte resistance to apoptosis and hyaluronan accumulation in the rabbit cornea. Acta Ophthalmol Scand 2001;79:603-8.
21. Sundar Raj N, Geiss MJ 3rd, Fantes F, et al. Healing of excimer laser ablated monkey corneas. An immunohistochemical evaluation. Arch Ophthalmol 1990;108:1604-1610.
22. Mohri M, Reinach PS, Kanayama A, et al. Suppression of the TNFalpha-induced increase in IL-1alpha exprestion by hypochlorite in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2002;43:3190- 5.
23. Andley UP, Fritz C, Morrison AR, et al. The role of prostaglandins E2 and F2 alpha in ultraviolet radiation-induced cortical cataracts in vivo. Invest Ophthalmol Vis Sci 1996;37:1539-48.
24. Pitts DG, Bergmanson JP, Chu LW. Ultrastructural analysis of corneal exposure to UV radiation. Acta Ophthalmol (Copenh) 1987;65:263-73.
25. Mammone T, Gan D, Goyarts E, et al. Salicylic acid protects the skin from UV damage. J Cosmet Sci 2006;57:203-4.
26. Di Girolamo N, Kumar RK, Coroneo MT, et al. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002;43:3430-7.
27. Di Girolamo N, Wakefield D, Coroneo MT. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006;47:2430-7.
28. Saika S, Miyamoto T, Yamanaka O, et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. Am J Pathol 2005;166:1393-403.
29. Boileau TW, Bray TM, Bomser JA. Ultraviolet radiation modulates nuclear factor kappa B activation in human lens epithelial cells. J Biochem Mol Toxicol 2003;17:108-13.
30. Fini ME, Stramer BM. How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea 2005;24:2-11S.
31. Stramer BM, Cook JR, Fini ME, et al. Induction of the ubiquitin-proteasome pathway during the keratocyte transition to the repair fibroblast phenotype. Invest Ophthalmol Vis Sci 2001;42:1698-706.
32. Moller-Pedersen T. Keratocyte reflectivity and corneal haze. Exp Eye Res 2004;78:553-60.
33. Cook JR, Mody MK, Fini ME. Failure to activate transcription factor NF-kappaB in corneal stromal cells (keratocytes). Invest Ophthalmol Vis Sci 1999;40:3122-31.
34. Tegeder I, Niederberger E, Israr E, et al. Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J 2001;15:2-4.
35. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998;396:77-80.
36. Zingarelli B, Sheehan M, Wong HR. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med 2003;31:105-11S.
37. Miyamoto T, Saika S, Ueyama T, et al. Cyclooxygenase 2 expression in rat corneas after ethanol exposure. J Cataract Refract Surg 2006;32:1736-40.
38. Miyamoto T, Saika S, Okada Y, et al. Expression of cyclooxygenase-2 in corneal cells after photorefractive keratectomy and laser in situ keratomileusis in rabbits. J Cataract Refract Surg 2004;30:2612-7.